COMMUNIQUÉS West-GlobeNewswire

Oculis’ DIAMOND Phase 3 Program in Diabetic Macular Edema to be Presented at Innovate Retina and Eyecelerator 2024

15/10/2024 - 10:00

ZUG, Switzerland, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven to save sight and improve eye care, today announced that an update [...]

Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer

15/10/2024 - 08:00

Avacta Group plc ("Avacta" or "the Group" or "the Company") Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer London, Oct. 15, 2024 – Avacta Group plc (AIM: [...]

Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024

15/10/2024 - 08:00

ORION CORPORATION PRESS RELEASE 15 OCTOBER 2024 at 9.00 EEST Orion publishes Interim Report for January–September 2024 and holds a webcast on 29 October 2024 Orion will publish Interim Report for January–September 2024 [...]

Former UK Prime Minister David Cameron Joins Oxford-Harrington Rare Disease Centre (OHC) as Chair of its Advisory Council

15/10/2024 - 08:00

Lord Cameron will lead international efforts to drive the OHC’s mission of delivering 40 new therapies for rare diseases into clinical trials over the next ten years OXFORD, UK and CLEVELAND, Ohio, US, 15 th October [...]

ONWARD® Medical Signs Agreement with CEA for Exclusive Rights to Clinatec’s WIMAGINE® Brain-Computer Interface (BCI) Technology

15/10/2024 - 07:30

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014) Company secures exclusive rights to incorporate the WIMAGINE BCI into its ARC-BCI™ [...]

ONWARD® Medical signe un accord avec le CEA pour obtenir les droits exclusifs de la technologie d’interface cerveau machine (BCI) WIMAGINE® de Clinatec

15/10/2024 - 07:30

CE COMMUNIQUÉ DE PRESSE CONTIENT DES INFORMATIONS PRIVÉES AU SENS DE L'ARTICLE (7)(1) DU RÈGLEMENT EUROPÉEN SUR LES ABUS DE MARCHÉ (596/2014) L'entreprise obtient les droits exclusifs pour intégrer l’interface cerveau [...]

argenx Highlights Data Showing Patient Impact Across Multiple Immunology Programs at 2024 American Association of Neuromuscular & Electrodiagnostic Medicine Annual Meeting and Myasthenia Gravis Foundation of America Scientific Sessions

15/10/2024 - 07:00

Long-term and real-world data of VYVGART® (efgartigimod alfa-fcab) and VYVGART® Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) demonstrate speed of onset, depth of response, and durability of response VYVGART [...]

Metagenomi Presents Compact SMART Editing Platform at AIChE 7th International Conference on CRISPR Technologies

15/10/2024 - 02:58

Poster presentation highlights SMART adenine base editors (ABEs) small enough to be packaged into a single adeno-associated virus (AAV) Data demonstrate compact SMART system optimizations allowing for therapeutically- [...]

Advanced Care Group Expands Healthcare Personnel Recruitment Services into UAE and Saudi Arabia

15/10/2024 - 02:00

DUBAI, United Arab Emirates, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Advanced Care Group (AC Group), a leader in healthcare recruitment, is thrilled to announce its expansion into the United Arab Emirates and Saudi Arabia, [...]

Tevogen CEO Reaffirms the Company’s Commitment to Closing the Information Gap on Its Multi-Billion-Dollar Assets, Following the Release of Revenue Projections

15/10/2024 - 00:43

WARREN, N.J., Oct. 14, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN ), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T [...]

Helius Medical Technologies, Inc. Announces Reimbursement Payment Determination Updates from CMS for its Portable Neuromodulation Stimulator (PoNS®) Controller and Mouthpiece

14/10/2024 - 23:00

-- Reimbursement Determination for the PoNS Mouthpiece (HCPCS code A4594) set at $2,963.30 on Lump Sum Payment to be challenged by Helius -- -- National Reimbursement Payment Determination from CMS for its PoNS [...]

Travere Therapeutics to Present Abstracts at American Society of Nephrology (ASN) Kidney Week 2024

14/10/2024 - 22:30

Data presentations highlight the results for FILSPARI ® (sparsentan), the only approved kidney-targeted medicine for IgA nephropathy, when used as a first-line treatment, and in combination with other therapies Late- [...]

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024

14/10/2024 - 22:30

Information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2024 (Article 223-16 of the General Regulations of the Autorité des Marchés Financiers ) Market : [...]

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024

14/10/2024 - 22:30

Information relative au nombre total des droits de vote et d’actions composant le capital social au 30 septembre 2024 (Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers) Place de cotation : NYSE [...]

The Joint Corp. Appoints Sanjiv Razdan President and Chief Executive Officer

14/10/2024 - 22:15

-Seasoned Franchise Executive to also Join the Company’s Board of Directors - SCOTTSDALE, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT) (“The Joint or “the Company”), the nation’s largest [...]

HeartSciences to Participate in the 2024 Maxim Healthcare Virtual Summit

14/10/2024 - 22:15

Southlake, TX, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (Nasdaq: HSCS; HSCSW) ("HeartSciences" or the "Company"), an artificial intelligence (AI)-powered medical technology [...]

Spectral AI, Inc. Announces Return of Founder Dr. J. Michael DiMaio as Chairman of the Board of Directors

14/10/2024 - 22:05

DALLAS, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment [...]

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

14/10/2024 - 22:05

The study found improvements in reading speed, vision-related quality of life, and suggested potential benefits of an interventional approach for patients with dry eye disease MENLO PARK, Calif., Oct. 14, 2024 (GLOBE [...]

The Association of American Physicians and Surgeons (AAPS) Sues to Block Expansion of the Federal Police State

14/10/2024 - 19:50

TUCSON, Ariz., Oct. 14, 2024 (GLOBE NEWSWIRE) -- The Association of American Physicians and Surgeons (“AAPS”) served a lawsuit on Oct 11, seeking to block the upcoming requirement that tens of millions Americans provide [...]